Enjoy complimentary customisation on priority with our Enterprise License!
The global amniotic membrane market size is estimated to grow by USD 2,298.09 million at a CAGR of 14.6% between 2022 and 2027.
Amniotic membranes are extensively used in wound repair and reconstruction therapies. They're a protective cover that lies over the wound, which is used to provide essential components. In addition, antimicrobial membrane reduces the formation of scars, monomeric inflammation, and pain as well as reducing the occurrence of microbial infection in wounds. The amniotic membrane has been preferred in the treatment of serious ulcers, among repair and reconstruction applications. The increasing prevalence of chronic ulcers is giving a boost to the demand for advanced wound care treatment procedures, thereby driving the growth of amniotic membrane sales globally. An adequate supply of wound healing components and growth factors that help accelerate the repair of diabetes foot ulcers are offered by amniotic membranes. Such benefits have increased the adoption of amniotic membranes in wound care management procedures.
Technavio has segmented the market into End-user, Type, and Geography.
It also includes an in-depth analysis of drivers, trends, and challenges.
To learn more about this report, Request Free Sample
The market share growth by the hospital segment will be significant during the forecast period. The amniotic membrane is a versatile biological material derived from the innermost layer of the placenta. Due to the unique characteristics of it, such as its ability to heal wounds with antimicrobial and bacterial activity, it has been applied in a variety of healthcare applications.
Get a glance at the market contribution of various segments View a PDF Sample
The hospital segment was valued at USD 702.98 million in 2017. There are a number of different uses for amniotic membranes in hospitals, like In the case of eye surgery, amniotic membranes may be used as a graft to enhance wound healing, decrease scar tissue and repair specific ophthalmological disorders. The amniotic membrane has the potential for gynecological and obstetric applications such as repairing vaginal or cervical lacerations, promoting post-surgical healing, and treating conditions such as intrauterine adhesions. The use of amniotic membranes in hospitals will drive the growth of the market focus during the forecast period.
Cryopreserved amniotic membranes are slow-freezes at -112 degrees Fahrenheit using preservation media such as Dulbeccos modified eagle medium (DMEM) and glycerol, which enables a slower rate of freezing without ice formation. Hesemeric membranes during prolonged storage requirements maintain the integrity of the amniotic membrane, as well as the local ECM architecture. The cryopreservation of key biological signalings proteins, such as the pentraxin 3 complex, fibronectin, collagen, and heavy chain hyaluronic acid present in ECM is helping to maintain their activity and quantity. The increasing coverage of cryopreserved products in reimbursement schemes of governments is promoting the demand for cryopreserved amniotic membranes. The number of tissue banks is also rising owing to the increasing availability of funding. Such a rise in capital funding helps tissue banks to enhance their storage capabilities and use the latest cryopreservation methods for amniotic membrane storage, thereby driving the growth of the segment during the forecast period.
Dehydrated amniotic membranes are preserved using a vacuum with low-temperature heat, which helps in retaining the devitalized cellular components. In contrast to cryopreserved membranes, dehydrated amniotic membranes can be stored and preserved at room temperature and, therefore, offer logistic benefits over cryopreserved amniotic membranes. Unlike cryopreserved membranes that are preserved for a period of 5 years, dehydrated amniotic membranes extend their shelf life up to 15 years. The dehydrated amniotic membrane in a variety of tissue sizes and thicknesses is being offered by several players on the market, according to medical needs. The low cost and low storage expense advantages over cryopreserved amniotic membranes, backed by the rising adoption of amniotic membranes in ophthalmic surgeries, are driving the growth of this segment. The cost of dehydrated membranes is 35% to 40% less compared with the costs of frozen membranes. In addition, at very low temperatures they are not dependent on specialized tissue banks for cryopreservation. Such benefits increase their preference for cryopreserved membranes in various surgical applications, which in turn accelerates the demand for the market
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 56% to the growth of the global market during the forecast period. Technavio’s analysts have explained the regional trends and drivers that will shape the market during the forecast period.
North America is the most dominating region in the global amniotic membrane market, with the US as the leading country. The growth in the North Americaamniotic membranes market is being driven by a growing acceptance of Advanced Wound Care treatments, due to increasing awareness about better healthcare options across people in the USA and Canada as well as increases in demand for orthopaedics. The demand for amniotic membranes as an advanced treatment for diabetic foot ulcers surged in the country as these products offered value-based and efficient treatment options by providing essential regenerative components to wound areas. This gave a boost to the revenue generated in the amniotic membrane market in North America.
The outbreak of the COVID-19 pandemic in 2020 significantly declined the demand for amniotic membranes in North America. However, with the lifting of the lockdown due to the initiation of vaccines in the second half of 2020, the operations in the clinics and hospitals that offer elective ophthalmic care resumed, which increased the demand for amniotic membranes. Moreover, in order to treat injuries or wounds, the providers on the market in question are continuing their R & D activities relating to the use of amniotic membranes. Research and development activities will thus drive the growth of the amniotic membrane market in North America during the forecast period.
Buy Now Full Report and Discover More
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market vendors, including:
Amnio Technology LLC - The company offers amniotic Membrane products such as chorion-free amniotic membranes.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The extensive use of amniotic membrane transplantation in ophthalmic surgeries is driving growth in the amniotic membrane market. Amniotic membrane transplantations have transformed the treatment of ophthalmic conditions, specifically treatments related to ocular surface reconstruction. Due to the characteristics of amniotic membranes enabling epithelial cells to migrate, strengthening cell adhesion, and encouraging epithelial diffraction, ocular surface reconstruction procedures have been significantly improved.
Moreover, amniotic membranes can modulate stromal scarring and have anti-inflammatory properties. Consequently, for the treatment of bullous keratitis, glaucoma or cataract, peripheral limbic stem cell deficiency, persistent epithelium defects, and corneoscleral ulcers, there is a growing trend among ophthalmologists to use amniotic membrane transplantation in cornea surface reconstruction. The increasing number of ophthalmic surgeries is promoting the demand for amniotic membranes among end-users such as hospitals and clinics. About 45 million people in the US use contact lenses for vision correction. Such eye infections and disorders increase the demand for ophthalmic reconstruction surgeries across the globe, thereby driving the growth of the market focus during the forecast period.
The growing reimbursement coverage for new products is a primary trend in the amniotic membrane market. Governments throughout the world are increasingly modifying their reimbursement structure for new health products, with a view to providing value-based care. Tissue-engineered products such as amniotic membranes are considered highly expensive owing to the involvement of a considerable amount of direct and indirect costs in sourcing, storage, transfer, and application.
However, government organizations and market vendors are focusing on reimbursing such costs and providing value-based care. This has led to the revision of reimbursement policies for amniotic membrane products. Suppliers are making information and guidance available on their websites, with a view to raising awareness of insurance coverage for different products. Such activities are reducing the cost of amniotic membranes and increasing awareness regarding coverage policies among patients and medical practitioners, which is expected to drive the growth of the market in focus during the forecast years.
The issues related to preservation and contamination are major challenges in the amniotic membrane market. End-users have observed reluctance to adopt the amniotic fluid transfer procedure due to fears of patients transmitting contagious diseases. An amniotic membrane is directly derived from amniotic sacs retrieved during cesarean and vaginal deliveries. Bacterial contaminants are commonly found in vaginal and placental areas that may contaminate the product. In addition, the presence of infectious diseases in a donor can transmit infections to his or her recipient. To avoid these events, vendors must carry out serology checks at the time of storage of amniotic membranes.
Additionally, amniotic membranes are required to be stored efficiently before their transplantation. It is a challenging task for market vendors and end users to store the amniotic membrane while ensuring optimal conditions. Issues that pose challenging sterile storage requirements for market vendors and end-users that operate in emerging regions with a lack of advanced storage options. This hampers the revenue growth of vendors, thereby declining the growth of the market in focus during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Amniotic Membrane Market Customer Landscape
The amniotic membrane market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest trends and growth opportunities from 2017 to 2027.
Amniotic Membrane Market Scope |
|
Report Coverage |
Details |
Page number |
161 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 14.6% |
Market growth 2023-2027 |
USD 2,298.09 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
12.65 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 56% |
Key countries |
US, Canada, Germany, UK, and France |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
Amnio Technology LLC, Applied Biologics LLC, BIOHEALING SRO, Celularity Inc., Flower Orthopedics Corp., Human Regenerative Technologies LLC, Integra Lifesciences Corp., Katena Products Inc., Merakris Therapeutics Inc., MiMedx Group Inc., Next Biosciences Pty Ltd., NuVision Biotherapies Ltd, Organogenesis Holdings Inc., Orthofix Medical Inc., Reea carewell products, Skye Biologics Holdings LLC, Stryker Corp., Surgenex LLC, SURGITECH INNOVATION, and TissueTech Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.